ID   BNL/R
AC   CVCL_B7TH
DR   Wikidata; Q112929336
RX   PubMed=23796475;
CC   Selected for resistance to: ChEBI; CHEBI:50924; Sorafenib (Nexavar).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6371 ! BNL 1ME A.7R.1
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=23796475; DOI=10.1016/j.jhep.2013.06.010;
RA   Kapanadze T., Gamrekelashvili J., Ma C., Chan C., Zhao F., Hewitt S.M.,
RA   Zender L., Kapoor V., Felsher D.W., Manns M.P., Korangy F.,
RA   Greten T.F.;
RT   "Regulation of accumulation and function of myeloid derived suppressor
RT   cells in different murine models of hepatocellular carcinoma.";
RL   J. Hepatol. 59:1007-1013(2013).
//